Case number 1:17-cv-01671
ViiV Healthcare Company et al v. Mylan Pharmaceuticals Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 8, 2020 | 9 | Motion for Leave to Appear Pro Hac Vice (4) |
| Jul 8, 2020 | 1 | Complaint (10) |
| Dec 4, 2018 | 38 | Patent/Trademark Report to Commissioner (1) |
| Dec 4, 2018 | 38 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,242,986. (Attachments: # (1) Stipulation and Order)(ceg) |
| Dec 4, 2018 | 38 | Stipulation and Order (4) |
| Dec 4, 2018 | 37 | Order (4) Docket Text: ORDER approving Stipulation and Order dismissing without prejudice the complaint against Mylan Pharmaceuticals Inc. (see D.I. 126 in lead case 17-1576) (***Civil Case Terminated). Signed by Judge Mitchell S. Goldberg on 12/4/2018. (ceg) |
| Aug 15, 2018 | 36 | Letter (1) Docket Text: Letter to Counsel from Judge Goldberg regarding Delaware Case Assignments. (gvw) |
| Jun 20, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER re (59 in 1:17-cv-01576-MSG-RL) STIPULATION TO EXTEND TIME the Deadline for the Parties to Jointly Submit a Proposed Protective Order to Friday, June 22, 2018 filed by ViiV Healthcare UK (No. 3) Limited, ViiV Healthcare Company, Shionogi & Co., Ltd. The deadline for the parties to jointly submit a proposed protective order is extended to Friday, June 22, 2018. Signed by Judge Richard A. Lloret on 6/20/2018. Associated Cases: 1:17-cv-01576-MSG-RL et al.(RL) |
| Apr 6, 2018 | 34 | Order (3) Docket Text: ORDER of Consolidation. All filings shall be made in lead case Civil Action No. 17-1576. Signed by Judge Mitchell S. Goldberg on 4/6/2018. Associated Cases: 1:17-cv-01576-MSG et al.(fms) |
| Apr 6, 2018 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:17-cv-01576-MSG. (fms) |
| Apr 5, 2018 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Rule 16 teleconference held on 4/5/2018. Associated Cases: 1:17-cv-01576-MSG et al.(fms) |
| Apr 3, 2018 | 33 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by James G. Gorman, III on behalf of Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc. (Gorman, James) |
| Apr 3, 2018 | 32 | Letter (2) Docket Text: Letter to The Honorable Mitchell S. Goldberg from James M. Lennon regarding Request for Rule 16 Conference be Held Telephonically. (Lennon, James) |
| Apr 2, 2018 | 31 | Order Setting Scheduling Conference (4) Docket Text: Order RESCHEDULING Rule 16 Conference to Thursday, April 5, 2018 at 12:00 PM before Judge Mitchell S. Goldberg at the James A. Byrne U.S. Courthouse, 601 Market Street, Philadelphia, PA, 19106, in Courtroom 6-A. Signed by Judge Mitchell S. Goldberg on 4/2/2018. Associated Cases: 1:17-cv-01576-MSG et al.(ceg) |
| Mar 30, 2018 | 30 | Main Document (20) Docket Text: REDACTED VERSION of (22 in 1:17-cv-01784-MSG) Proposed Discovery Plan, by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Attachments: # (1) Text of Proposed Order Proposed Scheduling Order [Reflecting Agreed Upon and Disputed Provisions])(Silver, Daniel) |
| Mar 30, 2018 | 30 | Text of Proposed Order Proposed Scheduling Order [Reflecting Agreed Upon and Dis (14) |
| Mar 30, 2018 | 30 | Redacted Document (20) |
| Mar 29, 2018 | 28 | Notice of Service (8) Docket Text: NOTICE OF SERVICE of Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited.(Silver, Daniel) |
| Mar 22, 2018 | 27 | Order (3) Docket Text: SO ORDERED re [23] Letter/Motion. (D.I. [12])MOTION to Dismiss for Improper Venue and for Failure to State a claim is ADMINISTRATIVELY CLOSED. STATUS REPORT ORDER:( Status Report due by 4/20/2018 or within fifteen (15) days of the Notice, whichever is earlier.) Signed by Judge Mitchell S. Goldberg on 3/20/2018. (nmfn) |
| Mar 15, 2018 | 26 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Mylan Pharmaceuticals Inc. and Mylan Laboratories Ltd.s Initial Disclosures filed by Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc..(Lennon, James) |
| Mar 15, 2018 | 25 | SO ORDERED (2) Docket Text: SO ORDERED, [24] MOTION for Pro Hac Vice Appearance of Attorney Shannon M. Bloodworth, Brandon M. White, Bryan D. Beel, and Emily J. Greb filed by Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc. Signed by Judge Mitchell S. Goldberg on 3/15/2018. (ceg) |
| Mar 14, 2018 | 24 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Shannon M. Bloodworth, Brandon M. White, Bryan D. Beel, and Emily J. Greb - filed by Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc.. (Lennon, James) |
| Mar 7, 2018 | 23 | Letter (3) Docket Text: Letter to The Honorable Mitchell S. Goldberg from James M. Lennon regarding Proposed Stay of Venue Briefing. (Lennon, James) |
| Feb 28, 2018 | 22 | Order Setting Scheduling Conference (4) Docket Text: ORDER that, upon consideration of a Stipulation filed on 2/14/18, in each of the above-captioned cases except for 17-1671, it is ORDERED: 1) The Oral Order of Magistrate Judge Christopher J. Burke, referenced in the Stipulation, is - in each of the above cases in which it was entered - VACATED. Accordingly, the Stipulation is DENIED AS MOOT. 2) A Rule 16 Conference is set for 4/5/2018 at 10:00 AM in the James A. Byrne U.S. Courthouse, 601 Market Street, Philadelphia, PA, in Courtroom 4B before Judge Mitchell S. Goldberg. 3) Counsel shall consult Judge Goldberg's Polices and Procedures prior to the conference, etc. 4) Counsel shall be prepared to discuss consolidation of the above-captioned cases during the Rule 16 Conference. Signed by Judge Mitchell S. Goldberg on 2/28/18. Associated Cases: 1:17-cv-01576-MSG et al.(gvw) |
| Feb 26, 2018 | 21 | SO ORDERED (2) Docket Text: SO ORDERED, [20] Stipulation to Extend Time. Set Briefing Schedule: re [12] MOTION to Dismiss for Improper Venue and for Failure to State a Claim. (Answering Brief due 3/12/2018). Signed by Judge Mitchell S. Goldberg on 2/26/2018. (ceg) |
| Feb 23, 2018 | 20 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME the Deadline for Plaintiffs' Answering Brief in Opposition to Defendant's Motion to Dismiss for Improper Venue and for Failure to State a Claim to Monday, March 12, 2018 (from Monday, February 26, 2018) - filed by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Silver, Daniel) |
| Feb 13, 2018 | 19 | Notice Requesting Removal of Co-Counsel (4) Docket Text: NOTICE requesting Clerk to remove Filko Prugo as co-counsel.. (Silver, Daniel) |
| Feb 7, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Carolyn Wall for ViiV Healthcare Company added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-01576-MSG et al.(ceg) |
| Jan 24, 2018 | 18 | Order (2) Docket Text: ORDER approving Stipulation to Extend Time (D.I. [17]). Set Briefing Schedule: re [12] MOTION to Dismiss for Improper Venue and for Failure to State a claim. (Answering Brief due 2/26/2018.). Signed by Judge Mitchell S. Goldberg on 1/23/2018. (fms) |
| Jan 23, 2018 | 17 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME Plaintiffs Answering Brief in Opposition to Defendants Motion to Dismiss for Improper Venue and for Failure to State a Claim to Monday, February 26, 2018 (from Friday, January 26, 2018) - filed by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Silver, Daniel) |
| Jan 19, 2018 | 16 | Redacted Document (5) Docket Text: REDACTED VERSION of [14] Declaration in Support of Defendants' Motion to Dismiss by Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc.. (Lennon, James) |
| Jan 19, 2018 | 15 | Redacted Document (19) Docket Text: REDACTED VERSION of [13] Opening Brief in Support, Defendants' Motion to Dismiss by Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc.. (Lennon, James) |
| Jan 18, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Mitchell S. Goldberg of the Eastern District of Pennsylvania (in lieu of Vacant Judgeship). Please include the initials of the Judge (MSG) after the case number on all documents filed. Associated Cases: 1:17-cv-01576-MSG, 1:17-cv-01634-MSG, 1:17-cv-01670-MSG, 1:17-cv-01671-MSG, 1:17-cv-01678-MSG, 1:17-cv-01737-MSG, 1:17-cv-01741-MSG and 1:17-cv-01784-MSG (rjb) |
| Jan 5, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Jan 3, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Dec 28, 2017 | N/A | SO ORDERED (0) |
| Dec 20, 2017 | N/A | SO ORDERED (0) |
| Dec 20, 2017 | 11 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Answer the Complaint to January 12, 2018 - filed by Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc.. (Lennon, James) |
| Dec 14, 2017 | 10 | Notice (Other) (4) Docket Text: NOTICE of Appearance (Lisa B. Pensabene) by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited (Silver, Daniel) |
| Dec 14, 2017 | 9 | Certifications for Filko Prugo, Daniel OBoyle, Carolyn Wall, and Caitlin Hogan (4) |
| Dec 14, 2017 | 9 | Main Document (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Filko Prugo, Daniel OBoyle, Carolyn Wall, and Caitlin Hogan - filed by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Attachments: # (1) Certifications for Filko Prugo, Daniel OBoyle, Carolyn Wall, and Caitlin Hogan)Motions referred to Christopher J. Burke.(Silver, Daniel) |
| Dec 8, 2017 | N/A | SO ORDERED (0) |
| Dec 8, 2017 | 8 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Answer the Complaint to December 29, 2017 - filed by Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc.. (Lennon, James) |
| Nov 22, 2017 | N/A | Case Assigned/Reassigned (0) |
| Nov 22, 2017 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited, Shionogi & Co., Ltd.. Mylan Pharmaceuticals Inc. served on 11/20/2017, answer due 12/11/2017. (Silver, Daniel) |
| Nov 22, 2017 | N/A | Remark (0) Docket Text: REMARK: If the parties jointly consent to have a Magistrate Judge conduct all proceedings in this case, including trial, then when Judge Burke enters a case schedule he will enter the respective pre-trial conference and trial dates onto his calendar and will honor them. Otherwise, in accordance with the District Court's procedures for "Assignment of Cases to Visiting Judges" (issued on May 26, 2017 and available on the District Court's website), then upon the filing of a case-dispositive motion (e.g., a motion to dismiss, a motion for judgment on the pleadings, a motion for summary judgment, or initiation of the claim construction process in a patent case), VAC cases will be considered ready for reassignment to a visiting District Judge. Whether the pre-trial conference and trial dates will stand after reassignment will depend on the availability of those dates on the visiting District Judge's calendar. Associated Cases: 1:17-cv-01670-VAC-CJB, 1:17-cv-01671-VAC-CJB, 1:17-cv-01678-VAC-CJB(dlb) |
| Nov 22, 2017 | N/A | Remark re Newer Attorneys (0) Docket Text: REMARK: The parties should be aware that the Court encourages the participation of newer attorneys in courtroom proceedings and at oral argument. Please see the Court's Standing Order Regarding Courtroom Opportunities for Newer Attorneys, a link to which is provided here for the parties' convenience:http://www.ded.uscourts.gov/sites/default/files/forms/StandingOrder2017.pdf Associated Cases: 1:17-cv-01670-VAC-CJB, 1:17-cv-01671-VAC-CJB, 1:17-cv-01678-VAC-CJB(dlb) |
| Nov 22, 2017 | N/A | Case Referred to Magistrate Judge (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke. (This matter has been assigned to the Vacant Judgeship and referred to a Magistrate Judge for handling through case-dispositive motions. The Magistrate Judge has full authority permitted by law to manage this matter, including entering schedules through trial, deciding non-dispositive matters and making recommendations as to the resolution of dispositive matters. Litigants and counsel are reminded that they have the option of consenting to the Magistrate Judge to handle the case in full, including trial, or consenting to having a particular motion resolved by the Magistrate Judge.) Associated Cases: 1:17-cv-01670-VAC-CJB, 1:17-cv-01671-VAC-CJB, 1:17-cv-01678-VAC-CJB (rjb) |
| Nov 20, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Mylan Pharmaceuticals Inc. on 11/20/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Nov 17, 2017 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc., Corporate Parent GlaxoSmithKline plc., Corporate Parent Shionogi Limited for ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited filed by ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (nmg) |
| Nov 17, 2017 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Shionogi & Co., Ltd. (nmg) |
| Nov 17, 2017 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,242,986. (nmg) |
| Nov 17, 2017 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/5/2017. Date of Expiration of Patent: 12/8/2029.Thirty Month Stay Deadline: 2/12/2021. (nmg) |
| Nov 17, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Nov 17, 2017 | 1 | Main Document (10) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2268589.) - filed by ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited, Shionogi & Co., Ltd.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(nmg) |
| Nov 17, 2017 | 1 | Civil Cover Sheet (2) |
| Nov 17, 2017 | 1 | Exhibit A (32) |
| Nov 17, 2017 | 1 | Complaint* (1) |
